A new method of controlling inflammation and sugar levels for oral and systemic disease prevention using a common diabetes drug has been discovered by a team of researchers at King's College London.

MIT engineers have developed an implantable device for Type 1 diabetes treatment. The device contains insulin-producing cells and self-generates oxygen by splitting bodily water vapor. Promising results in diabetic mice show stabilized glucose levels. This advancement could eliminate daily insulin injections, offering a groundbreaking solution for diabetes management.